Skip to main content
Premium Trial:

Request an Annual Quote

WuXi PharmaTech Taps NextCode's Software for Sequence Analysis

Premium

NEW YORK (GenomeWeb) – WuXi PharmaTech, an R&D capability and technology platform provider, said this week that Chinese researchers who use sequencing services provided by the firm's Genome Center will have access to NextCode Health's sequence analysis solutions.

According to WuXi, NextCode will work with the WuXi Genome Center to process its customers''s sequencing data and to generate reports that will describe the medical implications of the findings.

Financial and other terms of the agreement were not disclosed.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.